Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
05/03/2012 | US20120107244 MONOMERIC VARIANTS OF THE TETRAMERIC eqFP611 |
05/03/2012 | US20120107235 Alpha-Fetoprotein Immu31 Antibodies and Fusion Proteins and Methods of Use Thereof |
05/03/2012 | US20120107234 Pan-HER Antibody Composition |
05/03/2012 | DE102010043015A1 Verfahren zur Konzentration von Probenbestandteilen und Amplifikation von Nukleinsäuren A process for the concentration of sample components and amplification of nucleic acids |
05/03/2012 | CA2853613A1 Hbv treatment |
05/03/2012 | CA2819230A1 Methods and compositions for assessing and treating cancer |
05/03/2012 | CA2819117A1 Anti-sod1 antibodies and uses thereof |
05/03/2012 | CA2816321A1 Compositions and methods for inhibition of pcsk9 genes |
05/03/2012 | CA2816306A1 Isoprene synthase variants for improved production of isoprene |
05/03/2012 | CA2816291A1 Novel anti-dr5 antibody |
05/03/2012 | CA2816281A1 A plant homolog to autophagy protein p62 |
05/03/2012 | CA2816060A1 Rapid salmonella serotyping assay |
05/03/2012 | CA2816056A1 Treatment of interferon-related developmental regulator 1 (ifrd1) related diseases by inhibition of natural antisense transcript to ifrd1 |
05/03/2012 | CA2816050A1 Method for purifying human granulocyte-colony stimulating factor from recombinant e. coli |
05/03/2012 | CA2815905A1 Temperature-stable .beta.-pyranosidase |
05/03/2012 | CA2815888A1 Clostridium difficile-specific antibodies and uses thereof |
05/03/2012 | CA2815829A1 Modified valencene synthase polypeptides, encoding nucleic acid molecules and uses thereof |
05/03/2012 | CA2815769A1 Isolated polynucleotides expressing or modulating micrornas or targets of same, transgenic plants comprising same and uses thereof in improving nitrogen use efficiency, abiotic stress tolerance, biomass, vigor or yield of a plant |
05/03/2012 | CA2815277A1 Novel egfr-binding molecules and immunoconjugates thereof |
05/03/2012 | CA2815222A1 Cell fate conversion of differentiated somatic cells into glial cells |
05/03/2012 | CA2815116A1 Down-regulating gene expression in insect pests |
05/03/2012 | CA2815112A1 Murine model of inflammation with il33 n-terminal domain deletion |
05/03/2012 | CA2815096A1 Overexpression of plant mirnas for parasite control |
05/03/2012 | CA2814552A1 Luminophore-labeled molecules coupled with particles for microarray-based assays |
05/03/2012 | CA2814187A1 Drought tolerant plants and related constructs and methods involving genes encoding dtp6 polypeptides |
05/03/2012 | CA2795577A1 New compositions and methods for treatment of autoimmune and allergic diseases |
05/02/2012 | EP2447374A2 In vitro method for the prognosis or prediction of the response in patients with rheumatoid arthritis treated with agents that recognize the cd20 membrane receptor in b lymphocytes |
05/02/2012 | EP2447371A1 Plant promoters, terminators, genes, vectors and related transformed plants |
05/02/2012 | EP2447370A1 MicroRNA molecules |
05/02/2012 | EP2447369A2 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
05/02/2012 | EP2447368A2 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
05/02/2012 | EP2447367A2 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
05/02/2012 | EP2447366A1 Method of synthesizing single-stranded cDNA, method of preparing microarray sample, and method of detecting nucleic acid |
05/02/2012 | EP2447365A1 Cell-free protein synthesis solution, cell-free protein synthesis kit, and protein synthesis method |
05/02/2012 | EP2447364A1 Modified biotin-conjugated protein |
05/02/2012 | EP2447362A2 Alkaline cellulase variants |
05/02/2012 | EP2447360A1 Gene defects and mutant ALK kinase in human solid tumors |
05/02/2012 | EP2447359A1 Gene defects and mutant ALK kinase in human solid tumors |
05/02/2012 | EP2447283A2 Human monoclonal antibodies to activin receptor-like kinase-1 (ALK-1) |
05/02/2012 | EP2447281A1 Novel anti-PLGF antibody |
05/02/2012 | EP2447279A1 Methods and compositions for gene inactivation |
05/02/2012 | EP2447278A1 Novel immunogenic proteins of Leptospira |
05/02/2012 | EP2446896A1 Activin-ActRII Antagonists for use in Increasing Red Blood Cells, increasing reticulocyte levels, or promoting erythropoiesis |
05/02/2012 | EP2446890A1 High viscosity macromolecular compositions for treating ocular conditions |
05/02/2012 | EP2446886A1 Autophagy regulators and the uses thereof in the treatment of collagen VI defective Muscular Dystrophies |
05/02/2012 | EP2446054A1 Process for amplifying dna using tetraethylene glycol, kit of parts therefor and use thereof |
05/02/2012 | EP2446041A1 Biosynthesis of 1-alkenes in engineered microorganisms |
05/02/2012 | EP2446040A1 Methods for agrobacterium-mediated transformation of sugar cane |
05/02/2012 | EP2446039A1 Method for fermentatively preparing l-amino acids |
05/02/2012 | EP2446037A2 Treatment of down syndrome gene related diseases by inhibition of natural antisense transcript to a down syndrome gene |
05/02/2012 | EP2446036A2 Treatment of tumor necrosis factor receptor 2 (tnfr2) related diseases by inhibition of natural antisense transcript to tnfr2 |
05/02/2012 | EP2446035A1 Novel drugs for inhibition of gene expression |
05/02/2012 | EP2446034A1 Novel polynucleotide molecules for enhanced gene expression |
05/02/2012 | EP2446033A2 Method of preparing an adduct |
05/02/2012 | EP2446032A1 Expression of surrogate light chains |
05/02/2012 | EP2446031A1 Stabilizing alkylglycoside compositions and methods thereof |
05/02/2012 | EP2446030A1 Synthetic operon |
05/02/2012 | EP2446027A1 Protein |
05/02/2012 | EP2446025A2 Ketoreductase-mediated stereoselective route to alpha chloroalcohols |
05/02/2012 | EP2446023A2 Adult animals generated from induced pluripotent cells |
05/02/2012 | EP2446020A1 Dental stem cell reprogramming |
05/02/2012 | EP2446019A2 Recombinant ethanologenic bacteria |
05/02/2012 | EP2445930A1 Bacterial expression of an artificial gene for the production of crm197 and its derivatives |
05/02/2012 | EP2445929A1 A method for transforming a bacterium belonging to the streptococcus genus by natural competence |
05/02/2012 | EP2445928A1 Chimeric influenza virus-like particles comprising hemagglutinin |
05/02/2012 | EP2445927A1 Lipidated tumor- associated antigens and immunotherapeutic compositions |
05/02/2012 | EP2445334A1 Non human animal models for increased retinal vascular permeability |
05/02/2012 | EP2089528B1 A method for producing an l-amino acid using a bacterium of the genus escherichia with attenuated expression of any of the cynt, cyns, cynx or cynr genes or a combination thereof |
05/02/2012 | EP1804835B9 Multimeric constructs |
05/02/2012 | EP1664315B1 Aav vectors for in vivo gene therapy of rheumatoid arthritis |
05/02/2012 | EP1637881B1 Sample arraying/assembling device, its method, and apparatus using sample assembly |
05/02/2012 | EP1634951B1 Novel protein |
05/02/2012 | EP1633875B1 Wheat plants having increased tolerance to imidazolinone herbicides |
05/02/2012 | EP1389130B1 Use of osteopontin for the treatment and/or prevention of neurologic diseases |
05/02/2012 | EP1343822B1 Means for the diagnosis and therapy of ctcl |
05/02/2012 | EP1256348B1 Remedies for hepatitis c |
05/02/2012 | CN1902315B Endoglucanase STCE and cellulase preparation containing the same |
05/02/2012 | CN1231673B Polynucleotide and its use for modulating a defence response in plants |
05/02/2012 | CN102439447A Method for detecting substance in biological sample |
05/02/2012 | CN102439444A Measuring g protein coupled receptor activation |
05/02/2012 | CN102439176A Phosphodiesterase 4d7 as marker for malignant, hormone-sensitive prostate cancer |
05/02/2012 | CN102439174A Compositions and methods for diagnosing prostate cancer based on detection of slc45a3-elk4 fusion transcript |
05/02/2012 | CN102439158A Highly acidic chitosan-nucleic acid polyplex compositions |
05/02/2012 | CN102439157A Compositions for targeting conducting airway cells comprising adeno-associated virus constructs |
05/02/2012 | CN102439156A Bidirectional promoter from z. mais |
05/02/2012 | CN102439155A Auxotrophic, recombinant bcg strain pasteur and use thereof for combating human infections caused by parasites |
05/02/2012 | CN102439154A A polynucleotide and polypeptide sequence and methods thereof |
05/02/2012 | CN102439153A Compositions for stimulation of mammalian innate immune resistance to pathogens |
05/02/2012 | CN102439152A Rna interference mediated inhibition of the intercellular adhesion molecule 1 (icam-1)gene expression using short interfering nucleic acid (sina) |
05/02/2012 | CN102439151A Rna interference mediated inhibition of btb and cnc homology 1, basic leucine zipper transcription factor 1 (bach 1) gene expression using short interfering nucleic acid (sina) sequence listing |
05/02/2012 | CN102439150A Kanamycin antisense nucleic acid for the treatment of cancer |
05/02/2012 | CN102439149A Treatment of glial cell derived neurotrophic factor (gdnf) related diseases by inhibition of natural antisense transcript to gdnf |
05/02/2012 | CN102439148A Sirna conjugate and preparation method thereof |
05/02/2012 | CN102439147A Vangl1 peptides and vaccines including the same |
05/02/2012 | CN102439145A Carbohydrate degrading polypeptide and uses thereof |
05/02/2012 | CN102439143A Method of producing a lipolytic enzyme |
05/02/2012 | CN102439140A Chinese hamster ovary cell lines |
05/02/2012 | CN102439136A Mesenchymal stem cells producing inhibitory rna for disease modification |
05/02/2012 | CN102439134A Tuberculosis vaccines including recombinant bcg strains overexpressing phop, and/or phop regulon protein(s) |
05/02/2012 | CN102439045A Establishment of induced pluripotent stem cell using cell-permeable reprogramming transcription factor for customized stem cell therapy |